These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases. Boyd AS; Shakhtour B; Shyr Y J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467 [TBL] [Abstract][Full Text] [Related]
5. Association of vascular endothelial growth factor expression with patohistological parameters of cutaneous melanoma. Gacević M; Jović M; Zolotarevski L; Stanojević I; Novaković M; Miller K; Šuljagić V; Mijušković Ž; Vojvodić D Vojnosanit Pregl; 2016 May; 73(5):449-57. PubMed ID: 27430109 [TBL] [Abstract][Full Text] [Related]
6. Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions. Wang H; Shen SS; Wang H; Diwan AH; Zhang W; Fuller GN; Prieto VG J Cutan Pathol; 2003 Nov; 30(10):599-605. PubMed ID: 14744083 [TBL] [Abstract][Full Text] [Related]
7. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Miracco C; Cevenini G; Franchi A; Luzi P; Cosci E; Mourmouras V; Monciatti I; Mannucci S; Biagioli M; Toscano M; Moretti D; Lio R; Massi D Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946 [TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression. Einspahr JG; Thomas TL; Saboda K; Nickolof BJ; Warneke J; Curiel-Lewandrowski C; Ranger-Moore J; Duckett L; Bangert J; Fruehauf JP; Alberts DS Cancer; 2007 Dec; 110(11):2519-27. PubMed ID: 17932890 [TBL] [Abstract][Full Text] [Related]
10. Different patterns of expression of the erbB family of receptor tyrosine kinases in common nevi, dysplastic nevi, and primary malignant melanomas: an immunohistochemical study. Feinmesser M; Veltman V; Morgenstern S; Tobar A; Gutman H; Kaganovsky E; Tzabari C; Sulkes J; Okon E Am J Dermatopathol; 2010 Oct; 32(7):665-75. PubMed ID: 20559114 [TBL] [Abstract][Full Text] [Related]
11. Expression of the embryonic morphogen Nodal in cutaneous melanocytic lesions. Yu L; Harms PW; Pouryazdanparast P; Kim DS; Ma L; Fullen DR Mod Pathol; 2010 Sep; 23(9):1209-14. PubMed ID: 20495543 [TBL] [Abstract][Full Text] [Related]
12. The role of vascular endothelial growth factors and their receptors in malignant melanomas. Brychtova S; Bezdekova M; Brychta T; Tichy M Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336 [TBL] [Abstract][Full Text] [Related]
13. TSLC1 expression discriminates cutaneous melanomas from dysplastic nevi. You Y; Wang SH; Zhang JF; Zheng SY Melanoma Res; 2012 Dec; 22(6):430-5. PubMed ID: 23047161 [TBL] [Abstract][Full Text] [Related]
14. IMP-3 EXPRESSION IN BENIGN MELANOCYTIC NEVI, DYSPLASTIC NEVI AND MALIGNANT MELANOMA: PRELIMINARY FINDINGS IN BULGARIAN PATIENTS. Chokoeva AA; Ananiev J; Wollina U; Tana C; Lotti T; Cardoso JC; Tchernev G J Biol Regul Homeost Agents; 2015; 29(3):695-9. PubMed ID: 26403409 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of microtubule-associated protein 2 in melanocytic skin lesions. Gambichler T; Rotterdam S; Radkowski K; Altmeyer P; Kreuter A Am J Clin Pathol; 2009 May; 131(5):710-4. PubMed ID: 19369632 [TBL] [Abstract][Full Text] [Related]
19. Assessment of vascularity in common blue nevi, small/medium congenital nevocellular, common and dysplastic acquired melanocytic nevi and melanomas: a comparative study. Ioannidis EN; Aroni K; Kavantzas N Am J Dermatopathol; 2014 Mar; 36(3):217-22. PubMed ID: 24067800 [TBL] [Abstract][Full Text] [Related]